Arno Friedl

Person

Bergisch Gladbach, DE

People

Patents Grantslast 30 patents

Information Patent Grant
Substituted imidazotriazines
- Patent number 7,202,243
- Issue date Apr 10, 2007
- Bayer Healthcare AG
- Martin Hendrix
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Imidazotriazines for use as phosphodiesterase inhibitors
- Patent number 6,936,609
- Issue date Aug 30, 2005
- Bayer Healthcare AG
- Jens-Kerim Ergüden
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Arylsulphonamides and analogues
- Patent number 6,727,279
- Issue date Apr 27, 2004
- Bayer Aktiengesellschaft
- Joachim Mittendorf
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Aryl sulfonamides and analogues thereof and their use in the treatm...
- Patent number 6,573,278
- Issue date Jun 3, 2003
- Bayer Aktiengesellschaft
- Joachim Mittendorf
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Aryl sulphonamide amino acid esters and analogues
- Patent number 6,545,050
- Issue date Apr 8, 2003
- Bayer Aktiengesellschaft
- Joachim Mittendorf
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Use of known agonists of the central cannabinoid receptor CB1
- Patent number 6,525,087
- Issue date Feb 25, 2003
- Bayer Aktiengesellschaft
- Joachim Mittendorf
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Aryl sulphonamides and analogues
- Patent number 6,469,054
- Issue date Oct 22, 2002
- Bayer Aktiengesellshaft
- Joachim Mittendorf
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Use of known agonists of the central cannabinoid receptor CB1
- Patent number 6,284,788
- Issue date Sep 4, 2001
- Bayer Aktiengesellschaft
- Joachim Mittendorf
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Aryl sulfonamides and analogues thereof and their use in the treatm...
- Patent number 6,262,112
- Issue date Jul 17, 2001
- Bayer Aktiengesellschaft
- Joachim Mittendorf
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Benzisothiazolyl-substituted aminomethylchromans
- Patent number 5,942,529
- Issue date Aug 24, 1999
- Bayer Aktiengesellschaft
- Rudolf Schohe-Loop
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
Substituted imidazotriazines
- Publication number 20060166993
- Publication date Jul 27, 2006
- Bayer Healthcare AG
- Martin Hendrix
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Heterocyclically substituted imidazotriazines
- Publication number 20060166992
- Publication date Jul 27, 2006
- Bayer Healthcare A G
- Martin Hendrix
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Imidazotriazines for use as phosphodiesterase inhibitors
- Publication number 20040249148
- Publication date Dec 9, 2004
- Jens-Kerim Erguden
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Novel arylsulphonamides and analogues
- Publication number 20030073727
- Publication date Apr 17, 2003
- Joachim Mittendorf
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Arylsulfonamides and analogues
- Publication number 20020072529
- Publication date Jun 13, 2002
- Joachim Mittendorf
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Use of known agonists of the central cannabinoid receptor CB1
- Publication number 20010034344
- Publication date Oct 25, 2001
- Joachim Mittendorf
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Arno Friedl

Person

Patents Grantslast 30 patents

Substituted imidazotriazines

Imidazotriazines for use as phosphodiesterase inhibitors

Arylsulphonamides and analogues

Aryl sulfonamides and analogues thereof and their use in the treatm...

Aryl sulphonamide amino acid esters and analogues

Use of known agonists of the central cannabinoid receptor CB1

Aryl sulphonamides and analogues

Use of known agonists of the central cannabinoid receptor CB1

Aryl sulfonamides and analogues thereof and their use in the treatm...

Benzisothiazolyl-substituted aminomethylchromans

Patents Applicationslast 30 patents

Substituted imidazotriazines

Heterocyclically substituted imidazotriazines

Imidazotriazines for use as phosphodiesterase inhibitors

Novel arylsulphonamides and analogues

Arylsulfonamides and analogues

Use of known agonists of the central cannabinoid receptor CB1